FAP and liver cancer: In this study, our FAP-CAR T cells could slow the tumor growth in multiple types of tumors in different mice models, including liver cancer PDX NCG mice models, 4T1 allograft BALB/c models and Panc02 allograft C57BL/6 models, warranting their wide application prospect in clinical practice.